Fundraising Fox

Octave

Menlo Park, US · 7 known investors

octavebio.com ↗

Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

WH
William HagstromFounder and Chairman
DB
Doug BiehnPresident and CEO

Investors · 7

Northpond Ventures✓ verifiedBethesda
Sandbox Industries✓ verifiedChicago
Section 32✓ verified
Echo Health VenturesDurham
Hikma Ventures$5M
GreycroftreportedNew York
Obvious VenturesreportedSan Francisco

In the news